Table 4.
PRO questionnaires identified in reviewed clinical trials.
| PRO QUESTIONNAIRE NAME | ABBREVIATION | NUMBER OF REVIEWED CLINICAL TRIALS USING PRO n (%)* |
|---|---|---|
| Functional Assessment of Cancer Therapy—Breast | FACT-B | 18 (47.4%) |
| European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire—Core 30 | EORTC QLQ-C30 | 14 (36.8%) |
| EuroQol 5-Dimensions | EQ-5D | 8 (21.1%) |
| EORTC QLQ—Breast Cancer Module | EORTC QLQ-BR23 | 5 (13.2%) |
| Brief Pain Inventory | BPI | 3 (7.9%) |
| Functional Assessment of Cancer Therapy—General | FACT-G | 3 (7.9%) |
| MD Anderson Symptom Inventory | MDASI | 2 (5.3%) |
| Hospital Anxiety and Depression Scale | HADS | 2 (5.3%) |
| Rotterdam Symptom Checklist | RSCL | 2 (5.3%) |
| EuroQol 5-Dimension 5-Level | EQ-5D-5L | 2 (5.3%) |
| Functional Assessment of Chronic Illness Therapy—Fatigue | FACIT-F | 1 (2.6%) |
| Functional Assessment of Cancer Therapy—Endocrine Symptoms | FACT-ES | 1 (2.6%) |
| Multidimensional Assessment of Fatigue | MAF | 1 (2.6%) |
| Pittsburgh Sleep Quality Index | PSQI | 1 (2.6%) |
| Short Form Health Survey-36 | SF-36 | 1 (2.6%) |
| Somatic and Psychological Health Report questionnaire (somatic subscale) | SPHERE | 1 (2.6%) |
| Subject Significance Questionnaire | SSQ | 1 (2.6%) |
Note:
*
Counts not mutually exclusive.